Trial Profile
Rivastigmine in the Treatment of Postoperative Delirium: a Pilot Clinical Trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 May 2019
Price :
$35
*
At a glance
- Drugs Rivastigmine (Primary)
- Indications Cognition disorders; Delirium
- Focus Therapeutic Use
- 25 Jun 2012 Company added in the association field as reported by ClinicalTrials.gov.
- 06 Oct 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 06 Oct 2010 Actual initiation date (Oct 2010) added as reported by ClinicalTrials.gov.